These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 17405387)

  • 21. Getting in harmony. As markets change, hospitals struggle with pricing.
    Pallarito K
    Mod Healthc; 1997 Jun; 27(26):100-1, 106, 108-11. PubMed ID: 10167960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Price control as a strategy for pharmaceutical cost containment - what has been achieved in Norway in the period 1994-2004?
    Håkonsen H; Horn AM; Toverud EL
    Health Policy; 2009 May; 90(2-3):277-85. PubMed ID: 19042052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Price transparency's role in healthcare purchasing reform.
    Titus F
    Front Health Serv Manage; 2007; 23(3):29-31; discussion 37-8. PubMed ID: 17405390
    [No Abstract]   [Full Text] [Related]  

  • 24. How hospitals approach price transparency.
    Houk S; Cleverley JO
    Healthc Financ Manage; 2014 Sep; 68(9):56-62. PubMed ID: 25647890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The opportunity of price transparency.
    Healthcare Financial Management Association
    Healthc Financ Manage; 2007 Apr; 61(4):1-8. PubMed ID: 17427463
    [No Abstract]   [Full Text] [Related]  

  • 26. Transparency--will it lead us back to the future?
    Bonney RS
    Front Health Serv Manage; 2007; 23(3):33-6; discussion 37-8. PubMed ID: 17405391
    [No Abstract]   [Full Text] [Related]  

  • 27. Are you ready for pricing transparency?
    Healthc Financ Manage; 2006 Jun; 60(6):4 p following 32. PubMed ID: 16773982
    [No Abstract]   [Full Text] [Related]  

  • 28. Would greater transparency and uniformity of health care prices benefit poor patients?
    Kyle MK; Ridley DB
    Health Aff (Millwood); 2007; 26(5):1384-91. PubMed ID: 17848449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ongoing Challenges With Price Transparency in Hospital Charges for Hand Procedures.
    Rhee BS; Kalliainen LK
    J Hand Surg Am; 2023 Dec; 48(12):1263-1267. PubMed ID: 37676189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The growing imperative of effective pricing strategies and tools for not-for-profit hospitals.
    Griebl O; Skalka C
    Healthc Financ Manage; 2007 Oct; 61(10):76-80. PubMed ID: 17953186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supporting quality by building trust.
    Qual Lett Healthc Lead; 2003 May; 15(5):2-9, 1. PubMed ID: 12822550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Priceless. Healthcare consumers show little interest in chargemasters despite growing movement to mandate price disclosure.
    Fong T
    Mod Healthc; 2005 Mar; 35(13):6-7, 16, 1. PubMed ID: 15807089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mind your pricing cues.
    Anderson E; Simester D
    Harv Bus Rev; 2003 Sep; 81(9):96-103, 134. PubMed ID: 12964397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Price Transparency in Radiology-A Model for the Future.
    Anzai Y; Delis K; Pendleton RC
    J Am Coll Radiol; 2020 Jan; 17(1 Pt B):194-199. PubMed ID: 31918882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-validation of insurer and hospital price transparency data.
    Henderson MA; Mouslim MC
    Am J Manag Care; 2024 Aug; 30(8):e247-e250. PubMed ID: 39146482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wanted: clearer pricing. Bush pushes for consumers to get better price data.
    DoBias M
    Mod Healthc; 2006 Feb; 36(8):8-9. PubMed ID: 16515215
    [No Abstract]   [Full Text] [Related]  

  • 37. Lifting the lid off of pricing. With HHS moving to post what it pays for common procedures, the debate over healthcare pricing transparency is heating up.
    DoBias M
    Mod Healthc; 2006 Mar; 36(12):6-7, 16, 1. PubMed ID: 16579130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two years into the storm over pricing to and collecting from the uninsured--a hospital valuation expert examines the risk/return dynamics and asks: would fair pricing and fair medical debt repayment plans increase yields to hospitals and simultaneously mitigate these controversies?
    Unland JJ
    J Health Care Finance; 2005; 32(1):54-66. PubMed ID: 18972978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospitals respond to public disclosure of mortality, complications and prices.
    Perform Improv Advis; 2006 Mar; 10(3):32-5, 25. PubMed ID: 16619784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The many different prices paid to providers and the flawed theory of cost shifting: is it time for a more rational all-payer system?
    Reinhardt UE
    Health Aff (Millwood); 2011 Nov; 30(11):2125-33. PubMed ID: 22068405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.